Back
Franklin US Equity Index ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
73
USPX
Franklin US Equity Index ETF
Last Price:
$60.48
Seasonality Move:
0.5%
Sell
36
INKT
MiNK Therapeutics, Inc.
Last Price:
$12.20
Seasonality Move:
-18.07%
Buy
73
Franklin US Equity Index ETF (USPX)
is a Buy
Is Franklin US Equity Index ETF a Buy, Sell or Hold?
-
The current Franklin US Equity Index ETF [USPX] share price is $60.57. The Score for USPX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
USPX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.90. The Score for INKT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
USPX Stock Price Chart
What is Franklin US Equity Index ETF's stock price today?
-
The Franklin US Equity Index ETF share price today is $60.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USPX is experiencing buying pressure, which is a positive indicator for future bullish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.90The current trend is relatively stagnant and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
USPX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.81 | Buy |
| Relative Strength Index (14 RSI): | 60.03 | Buy |
| Chaikin Money Flow: | 16814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.67 - 60.39) | Buy |
| Bollinger Bands (100): | (56.85 - 59.79) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 48.25 | Sell |
| Chaikin Money Flow: | -34456 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.88 - 12.26) | Buy |
| Bollinger Bands (100): | (12.14 - 15.1) | Sell |
USPX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.77 | Buy |
| 20-day SMA: | 59.91 | Buy |
| 50-day SMA: | 59.41 | Buy |
| 200-day SMA: | 54.74 | Buy |
| 8-day EMA: | 42.9 | Buy |
| 20-day EMA: | 23.57 | Buy |
| 50-day EMA: | 10.84 | Buy |
| 200-day EMA: | 2.92 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.87 | Buy |
| 20-day SMA: | 11.72 | Buy |
| 50-day SMA: | 12.71 | Sell |
| 200-day SMA: | 11.93 | Sell |
| 8-day EMA: | 11.83 | Buy |
| 20-day EMA: | 11.93 | Sell |
| 50-day EMA: | 12.53 | Sell |
| 200-day EMA: | 12.21 | Sell |
Franklin US Equity Index ETF Earnings Growth & USPX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Franklin US Equity Index ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||